SE458362B - Furo-(3,4-c)-pyridinderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem - Google Patents

Furo-(3,4-c)-pyridinderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem

Info

Publication number
SE458362B
SE458362B SE8401841A SE8401841A SE458362B SE 458362 B SE458362 B SE 458362B SE 8401841 A SE8401841 A SE 8401841A SE 8401841 A SE8401841 A SE 8401841A SE 458362 B SE458362 B SE 458362B
Authority
SE
Sweden
Prior art keywords
groups
carbon atoms
group
alkoxy
furo
Prior art date
Application number
SE8401841A
Other languages
English (en)
Swedish (sv)
Other versions
SE8401841D0 (sv
SE8401841L (sv
Inventor
A Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838327815A external-priority patent/GB8327815D0/en
Application filed by Scras filed Critical Scras
Publication of SE8401841D0 publication Critical patent/SE8401841D0/xx
Publication of SE8401841L publication Critical patent/SE8401841L/xx
Publication of SE458362B publication Critical patent/SE458362B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
SE8401841A 1983-04-05 1984-04-03 Furo-(3,4-c)-pyridinderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem SE458362B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8309165 1983-04-05
GB838327815A GB8327815D0 (en) 1983-10-18 1983-10-18 Furo-(3 4-c)-pyridine derivatives

Publications (3)

Publication Number Publication Date
SE8401841D0 SE8401841D0 (sv) 1984-04-03
SE8401841L SE8401841L (sv) 1984-10-06
SE458362B true SE458362B (sv) 1989-03-20

Family

ID=26285725

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401841A SE458362B (sv) 1983-04-05 1984-04-03 Furo-(3,4-c)-pyridinderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem

Country Status (29)

Country Link
US (1) US4581363A (instruction)
JP (1) JPS59193888A (instruction)
KR (1) KR900005518B1 (instruction)
AU (1) AU582113B2 (instruction)
CA (1) CA1257269A (instruction)
CH (1) CH660191A5 (instruction)
DE (1) DE3412885C2 (instruction)
DK (1) DK157931C (instruction)
DZ (1) DZ629A1 (instruction)
EG (1) EG18150A (instruction)
ES (1) ES531285A0 (instruction)
FI (1) FI76804C (instruction)
FR (2) FR2543956B1 (instruction)
GR (1) GR79577B (instruction)
HK (1) HK11187A (instruction)
IE (1) IE57424B1 (instruction)
IL (1) IL71243A (instruction)
IN (1) IN160104B (instruction)
IT (1) IT1173770B (instruction)
LU (1) LU85262A1 (instruction)
MA (1) MA20084A1 (instruction)
MX (1) MX167397B (instruction)
MY (1) MY8600664A (instruction)
NL (1) NL190328C (instruction)
NO (1) NO161802C (instruction)
NZ (1) NZ207552A (instruction)
OA (1) OA07699A (instruction)
PT (1) PT78361B (instruction)
SE (1) SE458362B (instruction)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000053606A1 (en) 1999-03-08 2000-09-14 Medicure Inc. Pyridoxal analogues for vitamin b-6 disorders
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1210117A2 (en) * 1999-08-24 2002-06-05 Medicure International Inc. Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
ES2305994T3 (es) 2000-02-29 2008-11-01 Medicure International Inc. Fosfonatos cardioprotectores.
CA2404329A1 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
EP1299358B1 (en) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
AU2005304220A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
AU2006317440A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
IN156817B (instruction) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
EG18150A (en) 1992-08-30
PT78361A (en) 1984-05-01
MX167397B (es) 1993-03-22
IT8420396A0 (it) 1984-04-05
NO841322L (no) 1984-10-08
JPH0556353B2 (instruction) 1993-08-19
DK178084A (da) 1984-10-06
IT1173770B (it) 1987-06-24
FI841273L (fi) 1984-10-06
NO161802C (no) 1989-09-27
AU2640184A (en) 1984-10-11
NZ207552A (en) 1986-05-09
MA20084A1 (fr) 1984-12-31
JPS59193888A (ja) 1984-11-02
LU85262A1 (fr) 1984-10-24
US4581363A (en) 1986-04-08
NO161802B (no) 1989-06-19
IE57424B1 (en) 1992-09-09
NL190328B (nl) 1993-08-16
DK178084D0 (da) 1984-04-04
FI76804C (fi) 1988-12-12
FR2543829B1 (fr) 1986-11-21
CA1257269A (en) 1989-07-11
IL71243A (en) 1987-12-20
KR900005518B1 (ko) 1990-07-30
SE8401841D0 (sv) 1984-04-03
IE840826L (en) 1984-10-05
NL8401013A (nl) 1984-11-01
OA07699A (fr) 1985-08-30
AU582113B2 (en) 1989-03-16
MY8600664A (en) 1986-12-31
ES8601998A1 (es) 1985-11-01
FI841273A0 (fi) 1984-03-30
FR2543956A1 (fr) 1984-10-12
SE8401841L (sv) 1984-10-06
CH660191A5 (fr) 1987-03-31
ES531285A0 (es) 1985-11-01
FR2543829A1 (fr) 1984-10-12
DE3412885A1 (de) 1984-10-11
FI76804B (fi) 1988-08-31
PT78361B (en) 1986-05-28
IN160104B (instruction) 1987-06-27
IL71243A0 (en) 1984-06-29
DK157931C (da) 1990-08-27
GR79577B (instruction) 1984-10-30
DZ629A1 (fr) 2004-09-13
KR840008651A (ko) 1984-12-17
DE3412885C2 (de) 1990-10-04
NL190328C (nl) 1994-01-17
FR2543956B1 (fr) 1986-07-04
DK157931B (da) 1990-03-05
HK11187A (en) 1987-02-13

Similar Documents

Publication Publication Date Title
SE458362B (sv) Furo-(3,4-c)-pyridinderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
US4383998A (en) Furo-(3,4-c)-pyridine derivatives and their pharmaceutical use
US4735950A (en) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
CA2831716C (en) Pyrido[3,4-b]indolyl compounds for treatment of metabolic syndrome
EP0774257B1 (en) Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration
CN101659676B (zh) 一种硫代阿德福韦、替诺福韦肝靶向酯前体药物
US5180717A (en) Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
KR100251395B1 (ko) 피소스티그민 유도체와 이의 용도 및 이를 함유한 제약적 조제물
JP2006528949A5 (instruction)
CS200543B2 (en) Method of producing novel derivatives of pyrido-2,3-b-1,5-benzothiazepine
US5304548A (en) Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US3275654A (en) 1-isopropylamino-2-hydroxy-3-phenoxy-propanes and salts thereof
DK158003B (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridinderivat og farmaceutisk praeparat indeholdende en saadan forbindelse
EP0149475B1 (en) Medicaments for the treatment and prevention of liver damage
US3527871A (en) Method of treating arrhythmia
GB2137618A (en) Furo-(3,4-c)-pyridine derivatives
RU2045268C1 (ru) Противогистаминное и антиаллергическое средство и способ приготовления глутамината хинуклидил-3-дифенилкарбинола в виде раствора для инъекций
AT383806B (de) Verfahren zur herstellung neuer verbindungen von furo-(3,4-c)-pyridinderivaten und von deren salzen
US3868463A (en) Method of treating arrhythmia
US3484442A (en) Reserpine 3,5,3'-triiodothyroacetate
SU1739851A3 (ru) Способ получени производных тиено(3 @ ,4 @ :4,5)имидазо(2,1- @ )тиазола
RU2333751C1 (ru) Противовирусное средство
JPH0453870B2 (instruction)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401841-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8401841-5

Format of ref document f/p: F